OTCMKTS:GNMLF Genomma Lab Internacional (GNMLF) Stock Price, News & Analysis $1.13 0.00 (0.00%) (As of 10/18/2024 ET) Add Compare Share Share Stock Analysis Stock AnalysisChartHeadlinesShort Interest About Genomma Lab Internacional Stock (OTCMKTS:GNMLF) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get GNMLF alerts:Sign Up Key Stats Today's Range$1.13▼$1.1350-Day Range$0.97▼$1.1352-Week Range$0.79▼$1.13VolumeN/AAverage Volume7,456 shsMarket CapitalizationN/AP/E Ratio0.66Dividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewGenomma Lab Internacional, S.A.B. de C.V., together with its subsidiaries, provides pharmaceutical and personal care products primarily in Latin America. It develops, sells, and markets a range of branded products in the categories of anti-acne products, self-diagnosis, antibacterial, cream to improve the texture of scarred skin, shampoos, dandruff shampoos, soaps, razors, products to prevent hair loss, ointment for muscle pain, anti-fungal treatments for the relief of colitis, products to counter stress levels, anti-wrinkles, antacids, anti-ulcers, anti-flu, protection and sexual improvement, treatments against hemorrhoids, against varicose veins, osteoarthritis, ophthalmic medications, and infant nutrition. The company was incorporated in 1996 and is based in Mexico City, Mexico.Read More… Watch this before it gets removed (Ad)If you missed it, my emergency election broadcast is now available - but will be removed on Monday at midnight.Click here to watch it now. Receive GNMLF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Genomma Lab Internacional and its competitors with MarketBeat's FREE daily newsletter. Email Address GNMLF Stock News HeadlinesGenomma Lab Internacional S.A.B. de C.V. Third Quarter 2024 Earnings Results Conference CallOctober 4, 2024 | prnewswire.comGENOMMA LAB PHARMA MANUFACTURING FACILITY GRANTED PENDING GMP CERTIFICATION FOR THE MEXICAN MARKETOctober 2, 2024 | prnewswire.comDon’t Miss Out! Get 2 Hot AI Stocks for Under $10/Share 🚀Artificial Intelligence (AI) stocks are booming, and now is your chance to get in on the action — without breaking the bank! We’ve just uncovered 2 must-buy AI stocks trading for under $10/share, and they’re showing serious potential for growth.October 20, 2024 | Darwin (Ad)GENOMMA LAB INTERNACIONAL ANNOUNCES NINTH DIVIDEND PAYMENTSeptember 10, 2024 | prnewswire.comGenomma Lab Announces Strategic Bolt-On Acquisition of Four BrandsJuly 25, 2024 | prnewswire.comGenomma Lab Internacional Announces Results for the Second Quarter 2024July 24, 2024 | prnewswire.comGENOMMA LAB ANNOUNCES REFINANCING OF LONG-TERM LIABILITIES AND RELEASE OF REAL ESTATE COLLATERALJuly 22, 2024 | prnewswire.comGenomma Lab Internacional S.A.B. de C.V. Second Quarter 2024 Earnings Results Conference CallJuly 2, 2024 | prnewswire.comSee More Headlines GNMLF Stock Analysis - Frequently Asked Questions How have GNMLF shares performed this year? Genomma Lab Internacional's stock was trading at $0.8399 at the start of the year. Since then, GNMLF stock has increased by 34.5% and is now trading at $1.13. View the best growth stocks for 2024 here. How do I buy shares of Genomma Lab Internacional? Shares of GNMLF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolOTCMKTS:GNMLF CUSIPN/A CIKN/A Webwww.genommalab.com Phone525550810000FaxN/AEmployees1,614Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E Ratio0.66 Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 Stocks to Buy And Hold ForeverClick the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report This page (OTCMKTS:GNMLF) was last updated on 10/20/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredCNBC’s ‘Prophet’ issues urgent Fed warning"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | SponsoredShocking New Forecast From Bear Market ExpertAnybody who followed my recommendations could have gone 11-for-11 on the year. Now, for the first time, I'm...Opportunistic Trader | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredAdd $2T of Potential Magic to Your PortfolioRevolutionizing a whole $2T entertainment and licensing industry might sound like the stuff of fairytales. But...Elf Labs | SponsoredWhat do Nvidia and Amazon have in common?What do Nvidia and Amazon have in common? Well, other than being worth trillions… Both chose to collaborate wi...Miso Robotics | SponsoredNotice: Major payout due November 19th - are you on the list?On Tuesday, November 19, 2024 smart investors will collect their share of a $1.2 billion windfall... It's p...Behind the Markets | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genomma Lab Internacional, S.A.B. de C.V. Please log in to your account or sign up in order to add this asset to your watchlist. Share Genomma Lab Internacional With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.